These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 8712155)

  • 1. Short-term hemodynamic effect of a new oral PGI2 analogue, beraprost, in primary and secondary pulmonary hypertension.
    Saji T; Ozawa Y; Ishikita T; Matsuura H; Matsuo N
    Am J Cardiol; 1996 Jul; 78(2):244-7. PubMed ID: 8712155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Short- and long-term effects of the new oral prostacyclin analogue, beraprost sodium, in patients with severe pulmonary hypertension].
    Saji T; Ozawa Y; Nakayama T; Matsuura H; Hashiguchi R; Matsuo N; Muto H; Yamazaki J; Morishita T; Saito T
    J Cardiol; 1996 Apr; 27(4):197-205. PubMed ID: 8642506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beneficial hemodynamic effects of oral prostacyclin (PGI2) analogue, beraprost sodium, on a patient with primary pulmonary hypertension--a case report.
    Hashida H; Hamada M; Shigematsu Y; Ikeda S; Kuwahara T; Kawakami H; Hara Y; Kodama K; Kohara K; Hiwada K
    Angiology; 1998 Feb; 49(2):161-4. PubMed ID: 9482517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of beraprost sodium, an oral prostacyclin analogue, in patients with pulmonary arterial hypertension: a randomized, double-blind, placebo-controlled trial.
    Galiè N; Humbert M; Vachiéry JL; Vizza CD; Kneussl M; Manes A; Sitbon O; Torbicki A; Delcroix M; Naeije R; Hoeper M; Chaouat A; Morand S; Besse B; Simonneau G;
    J Am Coll Cardiol; 2002 May; 39(9):1496-502. PubMed ID: 11985913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beraprost: a review of its pharmacology and therapeutic efficacy in the treatment of peripheral arterial disease and pulmonary arterial hypertension.
    Melian EB; Goa KL
    Drugs; 2002; 62(1):107-33. PubMed ID: 11790158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vasoresponsiveness of sarcoidosis-associated pulmonary hypertension.
    Preston IR; Klinger JR; Landzberg MJ; Houtchens J; Nelson D; Hill NS
    Chest; 2001 Sep; 120(3):866-72. PubMed ID: 11555522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beraprost therapy for pulmonary arterial hypertension.
    Barst RJ; McGoon M; McLaughlin V; Tapson V; Rich S; Rubin L; Wasserman K; Oudiz R; Shapiro S; Robbins IM; Channick R; Badesch D; Rayburn BK; Flinchbaugh R; Sigman J; Arneson C; Jeffs R;
    J Am Coll Cardiol; 2003 Jun; 41(12):2119-25. PubMed ID: 12821234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Oral administration of beraprost sodium did not exacerbate pulmonary hypertension with CREST syndrome].
    Furukawa K; Ikeda S; Obase K; Muroya T; Oka H; Kojima M; Miyahara Y; Kohno S
    Nihon Naika Gakkai Zasshi; 2001 May; 90(5):881-3. PubMed ID: 11460359
    [No Abstract]   [Full Text] [Related]  

  • 9. Beraprost therapy in children with pulmonary hypertension secondary to congenital heart disease.
    Limsuwan A; Pienvichit P; Khowsathit P
    Pediatr Cardiol; 2005; 26(6):787-91. PubMed ID: 16132278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemodynamic and hormonal effects of beraprost sodium, an orally active prostacyclin analogue, in patients with secondary precapillary pulmonary hypertension.
    Ono F; Nagaya N; Kyotani S; Oya H; Nakanishi N; Miyatake K
    Circ J; 2003 May; 67(5):375-8. PubMed ID: 12736472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pharmacological and clinical properties of beraprost sodium, orally active prostacyclin analogue].
    Nishio S; Kurumatani H
    Nihon Yakurigaku Zasshi; 2001 Feb; 117(2):123-30. PubMed ID: 11233303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sildenafil and beraprost combination therapy in patients with pulmonary hypertension undergoing valvular heart surgery.
    Kim SY; Shim JK; Shim YH; Hong SW; Choi KH; Kwak YL
    J Heart Valve Dis; 2010 May; 19(3):333-40. PubMed ID: 20583396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perfusion lung scan as a prognostic indicator of response to beraprost sodium in idiopathic pulmonary arterial hypertension.
    Park SY; Moon DH; Park YB; Na JO; Whang HK; Lim BS; Lee SD
    Pulm Pharmacol Ther; 2006; 19(4):264-71. PubMed ID: 16139536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effects of beraprost sodium (a PGI2 derivative) on chronic hypoxic pulmonary hypertension in the rat].
    Saito M; Tatsumi K; Kasahara Y; Tani T; Kuriyama T
    Nihon Kyobu Shikkan Gakkai Zasshi; 1995 May; 33(5):497-504. PubMed ID: 7609334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacology of the single isomer, esuberaprost (beraprost-314d) on pulmonary vascular tone, IP receptors and human smooth muscle proliferation in pulmonary hypertension.
    Shen L; Patel JA; Norel X; Moledina S; Whittle BJ; von Kessler K; Sista P; Clapp LH
    Biochem Pharmacol; 2019 Aug; 166():242-252. PubMed ID: 31158340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of beraprost sodium on pulmonary vascular resistance in candidates for a Fontan procedure: a preliminary study.
    Takahashi K; Mori Y; Yamamura H; Nakanishi T; Nakazawa M
    Pediatr Int; 2003 Dec; 45(6):671-5. PubMed ID: 14651539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identical twins with primary pulmonary hypertension: beraprost vs epoprostenol.
    Berman Rosenzweig E; Schmitt KA; Garofano R; Barst RJ
    Chest; 2004 Mar; 125(3):1157-60. PubMed ID: 15006984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Additive effect of beraprost on pulmonary vasodilation by inhaled nitric oxide in children with pulmonary hypertension.
    Ichida F; Uese K; Tsubata S; Hashimoto I; Hamamichi Y; Fukahara K; Murakami A; Miyawaki T
    Am J Cardiol; 1997 Sep; 80(5):662-4. PubMed ID: 9295007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative effects of beraprost, a stable analogue of prostacyclin, with PGE(1), nitroglycerin and nifedipine on canine model of vasoconstrictive pulmonary hypertension.
    Tamura M; Kurumatani H; Matsushita T
    Prostaglandins Leukot Essent Fatty Acids; 2001 Mar; 64(3):197-202. PubMed ID: 11334556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Orally active prostacyclin analogue in primary pulmonary hypertension.
    Okano Y; Yoshioka T; Shimouchi A; Satoh T; Kunieda T
    Lancet; 1997 May; 349(9062):1365. PubMed ID: 9149701
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.